A detailed history of Jane Street Group, LLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 13,281 shares of PLSE stock, worth $209,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,281
Previous 28,706 53.73%
Holding current value
$209,175
Previous $321,000 27.73%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.83 - $21.83 $167,052 - $336,727
-15,425 Reduced 53.73%
13,281 $232,000
Q2 2024

Aug 14, 2024

BUY
$6.69 - $14.54 $6,516 - $14,161
974 Added 3.51%
28,706 $321,000
Q1 2024

May 15, 2024

SELL
$7.8 - $11.02 $45,598 - $64,422
-5,846 Reduced 17.41%
27,732 $241,000
Q4 2023

Feb 14, 2024

BUY
$3.85 - $12.84 $129,275 - $431,141
33,578 New
33,578 $410,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $585M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.